EGFR c.1123_1124delinsAG ;(p.A375R)

Variant ID: 7-55224342-GC-AG

NM_005228.3(EGFR):c.1123_1124delinsAG;(p.A375R)

This variant was identified in 21 publications

View GRCh38 version.




Publications:


Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro.

Biology
Richtig, Georg G; Kienzl, Melanie M; Rittchen, Sonja S; Roula, David D; Eberle, Jürgen J; Sarif, Zina Z; Pichler, Martin M; Hoefler, Gerald G; Heinemann, Akos A
Publication Date: 2023-05-12

Variant appearance in text: EGFR: A375R
PubMed Link: 37237519
Variant Present in the following documents:
  • Main text
  • biology-12-00706.pdf
View BVdb publication page



3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells.

International Journal Of Molecular Sciences
Vital, Patrik da Silva PDS; Bonatelli, Murilo M; Dias, Marina Pereira MP; de Salis, Larissa Vedovato Vilela LVV; Pinto, Mariana Tomazini MT; Baltazar, Fátima F; Maria-Engler, Silvya Stuchi SS; Pinheiro, Céline C
Publication Date: 2022-12-09

Variant appearance in text: EGFR: A375R
PubMed Link: 36555289
Variant Present in the following documents:
  • Main text
  • ijms-23-15650.pdf
View BVdb publication page



Proteasomal down-regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma.

Life Science Alliance
Romano, David D; García-Gutiérrez, Lucía L; Aboud, Nourhan N; Duffy, David J DJ; Flaherty, Keith T KT; Frederick, Dennie T DT; Kolch, Walter W; Matallanas, David D
Publication Date: 2022-10

Variant appearance in text: EGFR: A375R
PubMed Link: 36038253
Variant Present in the following documents:
  • LSA-2022-01445_review_history.pdf
View BVdb publication page



Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway.

Frontiers In Pharmacology
Wang, Lei L; Otkur, Wuxiyar W; Wang, Aman A; Wang, Wen W; Lyu, Yitong Y; Fang, Lei L; Shan, Xiu X; Song, Mingzhou M; Feng, Yan Y; Zhao, Yi Y; Piao, Hai-Long HL; Qi, Huan H; Liu, Ji-Wei JW
Publication Date: 2022

Variant appearance in text: EGFR: A375R
PubMed Link: 36034784
Variant Present in the following documents:
  • fphar-13-906043.pdf
View BVdb publication page



CB-RAF600E-1 exerts efficacy in vemurafenib-resistant and non-resistant-melanoma cells via dual inhibition of RAS/RAF/MEK/ERK and PI3K/Akt signaling pathways.

Saudi Journal Of Biological Sciences
Al Shahrani, Mesfer M; Rajagopalan, Prasanna P; Abohassan, Mohammad M; Alshahrani, Mohammad M; Alraey, Yasser Y
Publication Date: 2022-06

Variant appearance in text: EGFR: A375R
PubMed Link: 35592740
Variant Present in the following documents:
  • main.pdf
View BVdb publication page



DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF.

Life Science Alliance
Gutierrez-Prat, Nuria N; Zuberer, Hedwig L HL; Mangano, Luca L; Karimaddini, Zahra Z; Wolf, Luise L; Tyanova, Stefka S; Wellinger, Lisa C LC; Marbach, Daniel D; Griesser, Vera V; Pettazzoni, Piergiorgio P; Bischoff, James R JR; Rohle, Daniel D; Palladino, Chiara C; Vivanco, Igor I
Publication Date: 2022-09

Variant appearance in text: EGFR: A375R
PubMed Link: 35580987
Variant Present in the following documents:
  • LSA-2021-01235.pdf
View BVdb publication page



Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy.

Science Advances
Ng, Thomas S C TSC; Hu, Huiyu H; Kronister, Stefan S; Lee, Chanseo C; Li, Ran R; Gerosa, Luca L; Stopka, Sylwia A SA; Burgenske, Danielle M DM; Khurana, Ishaan I; Regan, Michael S MS; Vallabhaneni, Sreeram S; Putta, Niharika N; Scott, Ella E; Matvey, Dylan D; Giobbie-Hurder, Anita A; Kohler, Rainer H RH; Sarkaria, Jann N JN; Parangi, Sareh S; Sorger, Peter K PK; Agar, Nathalie Y R NYR; Jacene, Heather A HA; Sullivan, Ryan J RJ; Buchbinder, Elizabeth E; Mikula, Hannes H; Weissleder, Ralph R; Miller, Miles A MA
Publication Date: 2022-04-29

Variant appearance in text: EGFR: A375R
PubMed Link: 35486732
Variant Present in the following documents:
  • Main text
  • sciadv.abl6339_sm.pdf
  • sciadv.abl6339.pdf
View BVdb publication page



HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E.

Theranostics
Chang, Xiaoyu X; Zhang, Tianshun T; Wang, Qiushi Q; Rathore, Moeez Ghani MG; Reddy, Kanamata K; Chen, Hanyong H; Shin, Seung Ho SH; Ma, Wei-Ya WY; Bode, Ann M AM; Dong, Zigang Z
Publication Date: 2020

Variant appearance in text: ERBB: A375R
PubMed Link: 32863956
Variant Present in the following documents:
  • Main text
  • thnov10p9721.pdf
  • thnov10p9721s1.pdf
View BVdb publication page



A novel chalcone derivative suppresses melanoma cell growth through targeting Fyn/Stat3 pathway.

Cancer Cell International
Tang, Ling L; Long, Jing J; Li, Keke K; Zhang, Xu X; Chen, Xiang X; Peng, Cong C
Publication Date: 2020

Variant appearance in text: EGFR: A375R
PubMed Link: 32565740
Variant Present in the following documents:
  • Main text
  • 12935_2020_Article_1336.pdf
View BVdb publication page



In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma.

International Journal Of Molecular Sciences
Fattore, Luigi L; Campani, Virginia V; Ruggiero, Ciro Francesco CF; Salvati, Valentina V; Liguoro, Domenico D; Scotti, Lorena L; Botti, Gerardo G; Ascierto, Paolo Antonio PA; Mancini, Rita R; De Rosa, Giuseppe G; Ciliberto, Gennaro G
Publication Date: 2020-03-12

Variant appearance in text: EGFR: A375R
PubMed Link: 32178301
Variant Present in the following documents:
  • Main text
View BVdb publication page



Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines.

Cancers
Guo, Wei W; Tan, Hor-Yue HY; Chen, Feiyu F; Wang, Ning N; Feng, Yibin Y
Publication Date: 2020-02-10

Variant appearance in text: EGFR: A375R
PubMed Link: 32050640
Variant Present in the following documents:
  • Main text
View BVdb publication page



miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A.

Journal Of Experimental & Clinical Cancer Research : Cr
Caporali, Simona S; Amaro, Adriana A; Levati, Lauretta L; Alvino, Ester E; Lacal, Pedro Miguel PM; Mastroeni, Simona S; Ruffini, Federica F; Bonmassar, Laura L; Antonini Cappellini, Gian Carlo GC; Felli, Nadia N; Carè, Alessandra A; Pfeffer, Ulrich U; D'Atri, Stefania S
Publication Date: 2019-06-21

Variant appearance in text: EGFR: A375R
PubMed Link: 31227006
Variant Present in the following documents:
  • Main text
  • 13046_2019_Article_1238.pdf
View BVdb publication page



BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1.

Oncogenesis
Grimm, Johannes J; Hufnagel, Anita A; Wobser, Marion M; Borst, Andreas A; Haferkamp, Sebastian S; Houben, Roland R; Meierjohann, Svenja S
Publication Date: 2018-09-20

Variant appearance in text: EGFR: A375R
PubMed Link: 30237393
Variant Present in the following documents:
  • 41389_2018_Article_82.pdf
View BVdb publication page



Integrator orchestrates RAS/ERK1/2 signaling transcriptional programs.

Genes & Development
Yue, Jingyin J; Lai, Fan F; Beckedorff, Felipe F; Zhang, Anda A; Pastori, Chiara C; Shiekhattar, Ramin R
Publication Date: 2017-09-01

Variant appearance in text: EGFR: A375R
PubMed Link: 28982763
Variant Present in the following documents:
  • Main text
  • 1809.pdf
View BVdb publication page



Design and Development of Fluorescent Vemurafenib Analogs for In Vivo Imaging.

Theranostics
Mikula, Hannes H; Stapleton, Shawn S; Kohler, Rainer H RH; Vinegoni, Claudio C; Weissleder, Ralph R
Publication Date: 2017

Variant appearance in text: EGFR: A375R
PubMed Link: 28435463
Variant Present in the following documents:
  • thnov07p1257.pdf
View BVdb publication page



BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts.

Cell Reports
Kemper, Kristel K; Krijgsman, Oscar O; Kong, Xiangjun X; Cornelissen-Steijger, Paulien P; Shahrabi, Aida A; Weeber, Fleur F; van der Velden, Daphne L DL; Bleijerveld, Onno B OB; Kuilman, Thomas T; Kluin, Roel J C RJC; Sun, Chong C; Voest, Emile E EE; Ju, Young Seok YS; Schumacher, Ton N M TNM; Altelaar, A F Maarten AFM; McDermott, Ultan U; Adams, David J DJ; Blank, Christian U CU; Haanen, John B JB; Peeper, Daniel S DS
Publication Date: 2016-06-28

Variant appearance in text: EGFR: A375R
PubMed Link: 27320919
Variant Present in the following documents:
  • Main text
View BVdb publication page



Microphthalmia-associated transcription factor suppresses invasion by reducing intracellular GTP pools.

Oncogene
Bianchi-Smiraglia, A A; Bagati, A A; Fink, E E EE; Moparthy, S S; Wawrzyniak, J A JA; Marvin, E K EK; Battaglia, S S; Jowdy, P P; Kolesnikova, M M; Foley, C E CE; Berman, A E AE; Kozlova, N I NI; Lipchick, B C BC; Paul-Rosner, L M LM; Bshara, W W; Ackroyd, J J JJ; Shewach, D S DS; Nikiforov, M A MA
Publication Date: 2017-01-05

Variant appearance in text: EGFR: A375R
PubMed Link: 27181209
Variant Present in the following documents:
  • nihms775212.pdf
View BVdb publication page



Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation.

Cell Reports
Kim, Hyungsoo H; Frederick, Dennie T DT; Levesque, Mitchell P MP; Cooper, Zachary A ZA; Feng, Yongmei Y; Krepler, Clemens C; Brill, Laurence L; Samuels, Yardena Y; Hayward, Nicholas K NK; Perlina, Ally A; Piris, Adriano A; Zhang, Tongwu T; Halaban, Ruth R; Herlyn, Meenhard M MM; Brown, Kevin M KM; Wargo, Jennifer A JA; Dummer, Reinhard R; Flaherty, Keith T KT; Ronai, Ze'ev A ZA
Publication Date: 2015-06-09

Variant appearance in text: EGFR: A375R
PubMed Link: 26027934
Variant Present in the following documents:
  • Main text
View BVdb publication page



MITF Modulates Therapeutic Resistance through EGFR Signaling.

The Journal Of Investigative Dermatology
Ji, Zhenyu Z; Erin Chen, Yiyin Y; Kumar, Raj R; Taylor, Michael M; Jenny Njauw, Ching-Ni CN; Miao, Benchun B; Frederick, Dennie T DT; Wargo, Jennifer A JA; Flaherty, Keith T KT; Jönsson, Göran G; Tsao, Hensin H
Publication Date: 2015-07

Variant appearance in text: EGFR: A375R
PubMed Link: 25789707
Variant Present in the following documents:
  • Main text
  • nihms-670893.pdf
  • NIHMS670893-supplement-01.pdf
View BVdb publication page



Inhibition of HSP90 by AT13387 delays the emergence of resistance to BRAF inhibitors and overcomes resistance to dual BRAF and MEK inhibition in melanoma models.

Molecular Cancer Therapeutics
Smyth, Tomoko T; Paraiso, Kim H T KHT; Hearn, Keisha K; Rodriguez-Lopez, Ana M AM; Munck, Joanne M JM; Haarberg, H Eirik HE; Sondak, Vernon K VK; Thompson, Neil T NT; Azab, Mohammad M; Lyons, John F JF; Smalley, Keiran S M KSM; Wallis, Nicola G NG
Publication Date: 2014-12

Variant appearance in text: EGFR: A375R
PubMed Link: 25349308
Variant Present in the following documents:
  • Main text
View BVdb publication page